Dr. Ebert is an Associate Professor of Medicine at Harvard Medical School, co-Director of the Cancer Program at the Harvard Stem Cell Institute, and an Associate Member at the Broad Institute. He received a bachelor's degree from Williams College, a doctorate from Oxford University on a Rhodes Scholarship, and an MD from Harvard Medical School. He completed a residency in Internal Medicine at Massachusetts General Hospital and a fellowship in Hematology/Oncology at the Dana-Farber Cancer Institute before pursuing postdoctoral research at the Broad Institute. Dr. Ebert’s laboratory focuses on the molecular basis and treatment of hematologic malignancies, with a particular focus on myelodysplastic syndromes and acute leukemia. Recent work has elucidated the mechanism of action of lenalidomide, a drug that acts by modulating the function of an E3 ubiquitin ligase.